Literature DB >> 20513068

Effects of stem cell therapy on left ventricular remodeling after acute myocardial infarction: a meta-analysis.

Lan Sun1, Tiantai Zhang, Xi Lan, Guanhua Du.   

Abstract

OBJECTIVES: The objective was to perform a meta-analysis of clinical trials that investigated the effects of stem cell therapy on left ventricular remodeling in patients after acute myocardial infarction (AMI).
BACKGROUND: Intracoronary injection of stem cells in the acute phase of myocardial infarction has been proposed to replace the cardiomyocytes lost and to prevent deleterious pathological remodeling after myocardial infarction. Previously published trials have investigated the effects of cell therapy on left ventricular (LV) remodeling in AMI patients. However, the sample size of these studies is small and the conclusions are inconsistent.
METHODS: Trials were identified in the Cochrane Library, EMBASE, and PubMed databases, reviews, and reference lists of relevant articles. The weighted mean difference (WMD) was calculated for net changes in LV end-diastolic and end-systolic volumes (LVEDV and LVESV) by using fixed-effect models.
RESULTS: A total of 11 trials (13 comparisons) with 832 participants evaluated the association between stem cell therapy and changes in LVEDV. Compared with the control group, stem cell therapy did not influence the LVEDV changes from baseline to follow-up (WMD: - 1.76 mL, 95% confidence interval [CI]: - 4.61 to 1.08 mL, P = 0.233). A total of 9 trials (11 comparisons) with 797 participants evaluated the association between stem cell therapy and changes in LVESV. Compared with the control group, patients in the cell therapy group had a significantly greater reduction in LVESV from baseline to follow-up (WMD: - 5.08 mL, 95% CI: - 7.80 to - 2.37 mL, P < 0.001).
CONCLUSION: This meta-analysis suggests that cell therapy improves left ventricular contractility, but has no effect on LV remodeling. Copyright 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20513068      PMCID: PMC6653677          DOI: 10.1002/clc.20772

Source DB:  PubMed          Journal:  Clin Cardiol        ISSN: 0160-9289            Impact factor:   2.882


  38 in total

1.  Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines.

Authors:  H Kamihata; H Matsubara; T Nishiue; S Fujiyama; Y Tsutsumi; R Ozono; H Masaki; Y Mori; O Iba; E Tateishi; A Kosaki; S Shintani; T Murohara; T Imaizumi; T Iwasaka
Journal:  Circulation       Date:  2001-08-28       Impact factor: 29.690

Review 2.  Stem cell therapy in perspective.

Authors:  Bodo E Strauer; Ran Kornowski
Journal:  Circulation       Date:  2003-02-25       Impact factor: 29.690

3.  Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms.

Authors:  T Kinnaird; E Stabile; M S Burnett; C W Lee; S Barr; S Fuchs; S E Epstein
Journal:  Circ Res       Date:  2004-01-22       Impact factor: 17.367

Review 4.  Measuring inconsistency in meta-analyses.

Authors:  Julian P T Higgins; Simon G Thompson; Jonathan J Deeks; Douglas G Altman
Journal:  BMJ       Date:  2003-09-06

5.  A different outlook on the role of bone marrow stem cells in vascular growth: bone marrow delivers software not hardware.

Authors:  Matthias Heil; Tibor Ziegelhoeffer; Barend Mees; Wolfgang Schaper
Journal:  Circ Res       Date:  2004-03-19       Impact factor: 17.367

6.  Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial.

Authors:  Eriko Tateishi-Yuyama; Hiroaki Matsubara; Toyoaki Murohara; Uichi Ikeda; Satoshi Shintani; Hiroya Masaki; Katsuya Amano; Yuji Kishimoto; Kohji Yoshimoto; Hidetoshi Akashi; Kazuyuki Shimada; Toshiji Iwasaka; Tsutomu Imaizumi
Journal:  Lancet       Date:  2002-08-10       Impact factor: 79.321

7.  Heart failure and the aging population: an increasing burden in the 21st century?

Authors:  S Stewart; K MacIntyre; S Capewell; J J V McMurray
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

8.  Bone marrow cells regenerate infarcted myocardium.

Authors:  D Orlic; J Kajstura; S Chimenti; I Jakoniuk; S M Anderson; B Li; J Pickel; R McKay; B Nadal-Ginard; D M Bodine; A Leri; P Anversa
Journal:  Nature       Date:  2001-04-05       Impact factor: 49.962

9.  Bone marrow-derived cells do not incorporate into the adult growing vasculature.

Authors:  Tibor Ziegelhoeffer; Borja Fernandez; Sawa Kostin; Matthias Heil; Robert Voswinckel; Armin Helisch; Wolfgang Schaper
Journal:  Circ Res       Date:  2003-12-04       Impact factor: 17.367

Review 10.  Relation between left ventricular remodeling and clinical outcomes in heart failure patients with left ventricular systolic dysfunction.

Authors:  James E Udelson; Marvin A Konstam
Journal:  J Card Fail       Date:  2002-12       Impact factor: 5.712

View more
  10 in total

1.  Umbilical cord mesenchymal stem cell transplantation in the treatment of multiple sclerosis.

Authors:  Mingyao Meng; Ying Liu; Wenju Wang; Chuanyu Wei; Feifei Liu; Zhiqin Du; Yanhua Xie; Weiwei Tang; Zongliu Hou; Qihan Li
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

Review 2.  Vascular precursor cells in tissue injury repair.

Authors:  Xin Shi; Weihong Zhang; Liya Yin; William M Chilian; Jessica Krieger; Ping Zhang
Journal:  Transl Res       Date:  2017-02-21       Impact factor: 7.012

3.  Overexpression of FABP3 inhibits human bone marrow derived mesenchymal stem cell proliferation but enhances their survival in hypoxia.

Authors:  Suna Wang; Yifu Zhou; Oleg Andreyev; Robert F Hoyt; Avneesh Singh; Timothy Hunt; Keith A Horvath
Journal:  Exp Cell Res       Date:  2014-02-27       Impact factor: 3.905

4.  High-content adhesion assay to address limited cell samples.

Authors:  Jay W Warrick; Edmond W K Young; Eric G Schmuck; Kurt W Saupe; David J Beebe
Journal:  Integr Biol (Camb)       Date:  2013-02-21       Impact factor: 2.192

Review 5.  Therapeutic potential of mesenchymal stem cells for oral and systemic diseases.

Authors:  Reuben H Kim; Shebli Mehrazarin; Mo K Kang
Journal:  Dent Clin North Am       Date:  2012-07

Review 6.  Clinical trials for stem cell therapies.

Authors:  Alan Trounson; Rahul G Thakar; Geoff Lomax; Don Gibbons
Journal:  BMC Med       Date:  2011-05-10       Impact factor: 8.775

7.  Stem cells for cardiac repair: status, mechanisms, and new strategies.

Authors:  Ren Mingliang; Zhang Bo; Wang Zhengguo
Journal:  Stem Cells Int       Date:  2011-06-15       Impact factor: 5.443

Review 8.  Tracking of stem cells in vivo for cardiovascular applications.

Authors:  Nicole Azene; Yingli Fu; Jeremy Maurer; Dara L Kraitchman
Journal:  J Cardiovasc Magn Reson       Date:  2014-01-10       Impact factor: 5.364

9.  Efficacy and safety of bone marrow cell transplantation for chronic ischemic heart disease: a meta-analysis.

Authors:  Chun Xiao; Shijie Zhou; Yueqiang Liu; Huozhen Hu
Journal:  Med Sci Monit       Date:  2014-10-01

Review 10.  Adult Stem Cells in Vascular Remodeling.

Authors:  Dong Wang; LeeAnn K Li; Tiffany Dai; Aijun Wang; Song Li
Journal:  Theranostics       Date:  2018-01-01       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.